- Home
- LEXX vs BEST Comparison
LEXX vs BEST Comparison
Compare LEXX & BEST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEXX
- BEST
- Stock Information
- Founded
- LEXX 2004
- BEST 2007
- Country
- LEXX Canada
- BEST China
- Employees
- LEXX N/A
- BEST N/A
- Industry
- LEXX Biotechnology: Pharmaceutical Preparations
- BEST
- Sector
- LEXX Health Care
- BEST
- Exchange
- LEXX Nasdaq
- BEST Nasdaq
- Market Cap
- LEXX 49.3M
- BEST 54.7M
- IPO Year
- LEXX N/A
- BEST N/A
- Fundamental
- Price
- LEXX $2.98
- BEST $2.72
- Analyst Decision
- LEXX Strong Buy
- BEST
- Analyst Count
- LEXX 2
- BEST 0
- Target Price
- LEXX $11.00
- BEST N/A
- AVG Volume (30 Days)
- LEXX 96.0K
- BEST 20.4K
- Earning Date
- LEXX 11-18-2024
- BEST 11-20-2024
- Dividend Yield
- LEXX N/A
- BEST N/A
- EPS Growth
- LEXX N/A
- BEST N/A
- EPS
- LEXX N/A
- BEST N/A
- Revenue
- LEXX $411,019.00
- BEST $1,183,106,017.00
- Revenue This Year
- LEXX $82.02
- BEST N/A
- Revenue Next Year
- LEXX $95.09
- BEST N/A
- P/E Ratio
- LEXX N/A
- BEST N/A
- Revenue Growth
- LEXX 34.05
- BEST 11.57
- 52 Week Low
- LEXX $0.90
- BEST $1.85
- 52 Week High
- LEXX $6.85
- BEST $2.77
- Technical
- Relative Strength Index (RSI)
- LEXX 41.43
- BEST 43.08
- Support Level
- LEXX $2.91
- BEST $2.70
- Resistance Level
- LEXX $3.39
- BEST $2.75
- Average True Range (ATR)
- LEXX 0.20
- BEST 0.02
- MACD
- LEXX -0.02
- BEST -0.00
- Stochastic Oscillator
- LEXX 13.49
- BEST 48.08
About LEXX Lexaria Bioscience Corp.
Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH has the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. The Company has four reportable segments: Intellectual Property Licensing, B2B Production, Research and Development and Corporate. It earns maximum revenue from Intellectual Property Licensing.
About BEST BEST Inc. each representing twenty (20)
BEST Inc is a supply chain company. It provides a New Retail platform that offers technology-enabled integrated solutions such as supply chain management, express delivery, freight, merchandise sourcing, cross-border supply chain, last-mile, financial and value-added services. The Group operates in the following operating segments, Supply chain management services, Freight, Global and Others. The Others category principally relates to cross-border logistic coordination services. The majority of revenue generated from Freight segment.